Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
CAS:90131-68-3
Molecular Formula:C10H21N3O9
Alias
More Information
Tribulusterristrisextract; Puncturevine Caltrop Fruit Extract; Tribulus Terrestris Saponins; 2-[Carbamimidoyl(Methyl)Amino]Acetic Acid; 2,3,4,5,6-Pentahydroxyhexanoic Acid; Caltrop; Goathead; Gokshura; Tribulus; Puncture Vine; Bulgarian Tribulus
CAS:959-24-0
Molecular Formula:C12H21ClN2O3S
Alias
More Information
Sotalol HCL; Betapace; Betapace AF; Sotalex; Sotacor; Sorine; MJ 1999; Sotalol (Hydrochloride); Sotylize; Berlex; Darob; Mead Johnson 1999; Sotalol.HCl; Sotalol, HCl; (+/-)-Sotalol Hydrochloride; Betapace (TN); Sotalol (Betapace); Sotalol Monohydrochloride; 4'-(1-Hydroxy-2-(Isopropylamino)Ethyl)Methanesulfonanilide Monohydrochloride; Isopropylaminohydroxyethylmethanesulfonanilide Hydrochloride; N-[4-[1-Hydroxy-2-(Propan-2-Ylamino)Ethyl]Phenyl]Methanesulfonamide;Hydrochloride; N-Isopropyl-beta-(4-Methanesulfonamidophenyl)Ethanolamine Hydrochloride; 4-(2-Isopropylamino-1-Hydroxyaethyl)Methanesulfonailid Hydrochlorid; 4'-(1-Hydroxy-2-Isopropylaminoethyl)Methanesulphonanilide Hydrochloride; N-[4-[1-Hydroxy-2-(Isopropylamino)Ethyl]Phenyl]Methanesulfonamide Hydrochloride; 4-(2-Isopropylamino-1-Hydroxyaethyl)Methanesulfonailid Hydrochlorid [German]; N-(4-(1-Hydroxy-2-(Isopropylamino)Ethyl)Phenyl)Methanesulfonamide Hydrochloride; Methanesulfonamide, N-(4-(1-Hydroxy-2-((1-Methylethyl)Amino)Ethyl)Phenyl)-, Monohydrochloride; N-(4-{1-Hydroxy-2-[(1-Methylethyl)Amino]Ethyl}Phenyl)Methanesulfonamide Hydrochloride; N-{4-[1-Hydroxy-2-(Propan-2-Ylamino)Ethyl]Phenyl}Methanesulfonamide Hydrochloride; Sotalol Hydrochloride 100 Microg/mL in Acetonitrile; Methanesulfonanilide, 4'-(1-Hydroxy-2-(Isopropylamino)Ethyl)-, Monohydrochloride; N-(2-Hydroxy-2-{4-[(Methylsulfonyl)Amino]Phenyl}Ethyl)Propan-2-Aminium Chloride; N-[4-[1-Hydroxy-2-(Propan-2-Ylamino)Ethyl]Phenyl]Methanesulfonamide Hydrochloride; 4'-[1-Hydroxy-2-(Isopropylamino)Ethyl]Methanesulfonanilide Monohydrochloride; Methanesulfonanilide, 4'-[1-Hydroxy-2-(Isopropylamino)Ethyl]-, Monohydrochloride; N-(4-[1-Hydroxy-2-(Isopropylamino)Ethyl]Phenyl)Methanesulfonamide Hydrochloride; N-[4-[1-Hydroxy-2-[(1-Methylethyl)Amino]Ethyl]Phenyl]Methanesulfonamide Hydrochloride; N-{4-[1-Hydroxy-2-(Isopropylamino)Ethyl]Phenyl}Methanesulfonamide Hydrochloride; Methanesulfonamide, N-[4-[1-Hydroxy-2-[(1-Methylethyl)Amino]Ethyl]Phenyl]-, Monohydrochloride; Sorine (TN); (y)-Sotalol Hydrochloride; (?)-Sotalol Hydrochloride; Sotalol Hydrochloride- Bio-X; ( Inverted Question mark)-Sotalol Hydrochloride; Sotylize Component Sotalol Hydrochloride; (+/-)-Sotalol Hydrochloride, Analytical Standard; Sotalol Hydrochloride Component OF Sotylize; (+/-)-Sotalol Hydrochloride, >=98% (TLC), Powder; Methanesulphone, 4'-(1-Hydroxy-2-Isopropylaminoethyl)-; Sotalol Hydrochloride 1.0 mg/ml in Methanol (as free base); [(Isopropylamino)Hydroxyethyl]Methanesulfonanilide Hydrochloride; 4'-[1-Hydroxy-2-(Isopropylamino)Ethyl]Methanesulfonanilide Hydrochloride; 4'-[2-(Isopropylamino)-1-Hydroxyethyl]Methanesulfonanilide Hydrochloride; 4'-[2-(Isopropylamino)-1-Hydroxyethyl]Methanesulfonanilide Monohydrochloride; 4-[2-(Isopropylamine)-1-Hydroxyethyl]Methanesulfonanilide Hydrochloride; N-Isopropyl-.beta.-(4-Methanesulfonamidophenyl)Ethanolamine Hydrochloride; p-[1-Hydroxy-2-(Isopropylamino)Ethyl]Methanesulfonanilide Hydrochloride; Sotalol Hydrochloride, United States Pharmacopeia (USP) Reference Standard; Metanosulfonamida, N-[4-[1-Hidroxi-2-[(1-Metiletil)Amino]etil]Fenil]-, Clorhidrato (1:1); N-(4-{1-Hydroxy-2-[(Propan-2-yl)Amino]Ethyl}Phenyl)Methanesulfonamide Hydrochloride; N-[4-[1-Oxidanyl-2-(Propan-2-Ylamino)Ethyl]Phenyl]Methanesulfonamide Hydrochloride; Methanesulfonamide, N-(4-(1-Hydroxy-2-((1-Methylethyl)Amino)Ethyl)Phenyl)-, Hydrochloride (1:1); Methanesulfonamide, N-[4-[1-Hydroxy-2-[(1-Methylethyl) Amino]Ethyl]Phenyl]-, Monohydrochloride
Brief Introduction
This product is β Receptor blockers β The blocking effect of receptor is weaker than that of propranolol (Propranolol), about 1/3 of propranolol; The local anesthetic effect and "Quinidine like" effect are only 1/300 of propranolol. Its antiarrhythmic effect is caused by prolonging the time of Action potential, and has nothing to do with the local anesthetic effect. This product is easy to be absorbed orally, has a rapid effect, has little inhibition on myocardium, and is safe and effective. It is clinically used to treat arrhythmia caused by multiple reasons, especially atrial and ventricular premature beats, and can also be used for sinus and supraventricular tachycardia, Atrial fibrillation, etc; It can also be used for angina pectoris to reduce the number of attacks and the amount of Nitroglycerin, and improve exercise tolerance; It can also be used for congestive heart failure and hypertension. This product has minimal toxic side effects and may cause bradycardia, but it does not exacerbate congestive heart failure
CAS:98048-97-6
Molecular Formula:C30H46NO7P
Alias
More Information
4-Cyclohexyl-1-[2-[(2-Methyl-1-Propanoyloxy-Propoxy)-(4-Phenylbutyl)Phosphoryl]Acetyl]; Fosinopril,(4S)-4-Cyclohexyl-1-[(Rs)-2-Methyl-1-(Propionyloxy)Propoxy]-(4-Phenylbutyl)Phosphinylacetyl-L-Proline; L-Proline, 4-Cyclohexyl-1-(R)-(1S)-2-Methyl-1-(1-Oxopropoxy)Propoxy(4-Phenylbutyl)Phosphinylacetyl-, (4S)-; Fosenopril; [1[S^^ (R^^)],2α,4β]-4-Cyclohexyl-1-[[[2-Methyl-1-(1-Oxopropoxy)-Propoxy](4-Phenylbutyl)Phosphinyl]Acetyl]-L-Proline; Secorvas; Sq-28555; Staril
Brief Introduction
1. Mild, moderate and severe hypertension: it can be used as the first choice medicine and when other antihypertensive drugs are ineffective.
2. Myocardial ischemia: it can reduce myocardial oxygen consumption, increase myocardial oxygen supply, Bi directionally treat myocardial ischemia, reduce the number of angina attacks and the amount of nitrates.
3. Treatment of heart failure: it plays a role by dilating blood vessels and reducing water and sodium retention, and can be used as the first choice medicine.
CAS:64679-65-8
Molecular Formula:C5H7N3O2S
Alias
More Information
[(3-Methyl-1H-1,2,4-Triazol-5-yl)thio]Acetic acid; 5-Methyl-1H-1,2,4-Triazol-s-yl)thio}-Acetic acid; Tiazotic acid; (5-Methyl-1H-[1,2,4]Triazol-3-Ylmercapto)-Essigsaeure; 2-(5-Methyl-2H-1,2,4-Triazol-3-Ylthio)Acetic acid; [(5-Methyl-1H-1,2,4-Triazol-3-yl)thio]Acetic acid(Saltdata: FREE); (5-Methyl-1H-[1,2,4]Triazol-3-Ylmercapto)-Acetic acid; 2-(5-Methyl-1H-1,2,4-Triazol-3-Ylthio)Aceticacid
Brief Introduction
Cardio cerebrovascular agents
CAS:1350653-20-1
Molecular Formula:C19H16F2N8O2
Alias
More Information
Methyl (4,6-Diamino-2-(5-Fluoro-1-(2-Fluorobenzyl)-1H-Pyrazolo[3,4-b]Pyridin-3-yl)Pyrimidin-5-yl)Carbamate; BAY-1021189; UNII-LV66ADM269; Carbamic acid, N-[4,6-Diamino-2-[5-Fluoro-1-[(2-Fluorophenyl)Methyl]-1H-Pyrazolo[3,4-b]Pyridin-3-yl]-5-Pyrimidinyl]-, Methyl Ester; Vericiguat (BAY 1021189); MK-1242
Brief Introduction
Vericiguat (BAY1021189, Verquvo) is a potent, oral and soluble guanylate cyclase (sGC) stimulator.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!